Project Grant R21CA309305
Award Date 5/1/26
Completion Date 4/30/28
Dollars Obligated $381K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New Orleans, LA 70112, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Louisiana State University Health Sciences Center-Shreveport a $1.575 million Project Grant under the Cancer Biology Research program (CFDA 93.396) on September 12, 2025, with a completion date of July 31, 2029. This award funds investigative research examining the mechanisms by which differential activation of the triacylglycerol pathway in neural fibroblasts promotes neurogenesis and prostate cancer progression. The...
- Federal Project Grant Award Summary Rice University received a $104,278 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective January 11, 2026, with completion targeted for June 30, 2026. The award supports the development of an automated multimodal, multiscale deep learning algorithm for cervical cancer screening in low- and middle-income countries (LMICs). Building on existing low-cost multimodal colposcope hardware...
- Federal Project Grant Award Summary Award Details: Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) received a $3.28 million Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393). The award was obligated on August 15, 2025, with a project completion date of July 31, 2029. Products and Services: The funded project will develop and deliver English and Spanish-language smartphone-based Embodied...
- Federal Project Grant Award Summary The National Cancer Institute awarded Louisiana State University Health Sciences Center-Shreveport $416,040 on July 7, 2025, under the Cancer Treatment Research program (CFDA 93.395) to develop and evaluate an engineered oncolytic herpes simplex virus-1 (HSV-1) variant designed to enhance cancer immunotherapy. The research focuses on creating OHSV-1(ICP6MUT), a novel viral therapeutic that restores necroptosis—a highly immunogenic form of cell death—by...
- Federal Project Grant Award Summary New York University received a $442,750 Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a systematic study of policy implementation strategies for cervical cancer control in African low- and middle-income countries. The award, dated September 23, 2025, with completion targeted for August 31, 2027, will deliver empirically-grounded research identifying determinants of...
- Federal Grant Award Summary The National Cancer Institute awarded The Washington University a $160,093 Project Grant effective May 1, 2026, through April 30, 2028, under the Cancer Cause and Prevention Research program (CFDA 93.393). The grant supports research investigating perceptions and informational needs regarding risk-based prostate cancer screening among screening-eligible men. The research addresses disparities in prostate-specific antigen (PSA) screening practices, particularly among...
- The National Cancer Institute (NCI) awarded a $621,406 Project Grant on August 1, 2025, under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) to Fred Hutchinson Cancer Center to evaluate a multilevel intervention designed to improve follow-up colonoscopy completion rates among patients with abnormal Fecal Immunochemical Tests (FIT) in safety-net healthcare settings. The PROACT (Promoting Follow-up of Abnormal Colorectal Cancer Screening Tests through Multilevel...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded UCSF a $724,840 Project Grant effective August 21, 2025, through July 31, 2030, under the Cancer Cause and Prevention Research program (CFDA 93.393) to investigate the relationship between persistent poverty and colorectal cancer risk through biological, behavioral, and place-based mechanisms. The research leverages existing data from two large population-based cohorts—the Multiethnic Cohort Study (MEC) and...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $401,115 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded May 1, 2026, with completion scheduled for April 30, 2028. The project addresses the persistent research-to-practice gap in cancer control by elucidating the mechanisms of Expert Recommendations for Implementing Change (ERIC) strategies through an...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the University of Oklahoma Health Sciences Center a $592,731 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) beginning May 15, 2026, and concluding April 30, 2031. This award supports a randomized controlled trial to improve prostate cancer screening among Black men in Oklahoma through development and validation of the Prostate Cancer Genius App (PCGA), a smartphone-based mobile health...